VG
Venu Gopal Veldi
About Venu Gopal Veldi
Data last updated:
Venu Gopal Veldi is a Director at Chemxzen Labs Private Limited (since 2019), Director at Synventia Pharma Private Limited (since 2020) and Director at Atom Fine Chemicals Private Limited (since 2020). The companies operate in Pharma and Chemicals and Materials. The 3 current companies with reported revenue have a combined latest revenue of ₹8.12 Cr; the largest is Chemxzen Labs Private Limited at ₹6.37 Cr (FY 2024). Earlier, Venu Gopal Veldi was a Director at Hts Biopharma Private Limited (2012–2013).
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
| Director | 23 May 2019 | 2019 | ₹6.37 Cr (FY 2024) | Active | |
| Director | 28 Oct 2020 | 2020 | ₹1.38 Cr (FY 2024) | Active | |
| Director | 07 Dec 2020 | 2020 | ₹36.3 Lakh (FY 2024) | Active |
Previous companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
| Director | 16 Apr 2012 | 2012 | ₹6.71 Cr (FY 2024) | Active |
Explore Director's current and past company associations Uncover their professional journey today!
Board colleagues of Venu Gopal Veldi
| Name | DIN | Company | Designation |
|---|---|---|---|
| Srikanth Yerra | 08460242 | Chemxzen Labs Private Limited | Director |
| Srinivasa Rao Papineni | 09097057 | Synventia Pharma Private Limited | Director |
| Surendar Velagapuri | 05206482 | Synventia Pharma Private Limited | Director |
| Sreenivasulu Guntha | 02423651 | Atom Fine Chemicals Private Limited | Director |
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Venu Gopal Veldi
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Venu Gopal Veldi
Venu Gopal Veldi currently holds 3 directorships: Chemxzen Labs Private Limited (Director, since 23 May 2019, revenue ₹6.37 Cr (FY 2024)); Synventia Pharma Private Limited (Director, since 28 Oct 2020, revenue ₹1.38 Cr (FY 2024)); Atom Fine Chemicals Private Limited (Director, since 07 Dec 2020, revenue ₹36.3 Lakh (FY 2024)).
Venu Gopal Veldi was first appointed on 16 Apr 2012 as Director at Hts Biopharma Private Limited. The most recent appointment on record is 07 Dec 2020 at Atom Fine Chemicals Private Limited.
The 3 current companies of Venu Gopal Veldi that report revenue have a combined latest revenue of ₹8.12 Cr: Chemxzen Labs Private Limited ₹6.37 Cr (FY 2024); Synventia Pharma Private Limited ₹1.38 Cr (FY 2024); Atom Fine Chemicals Private Limited ₹36.3 Lakh (FY 2024).
Venu Gopal Veldi held 1 earlier board appointment: Hts Biopharma Private Limited (Director, 16 Apr 2012 to 23 Sep 2013).
The current boards of Venu Gopal Veldi's companies include Srikanth Yerra (Chemxzen Labs Private Limited), Srinivasa Rao Papineni (Synventia Pharma Private Limited), Surendar Velagapuri (Synventia Pharma Private Limited), Sreenivasulu Guntha (Atom Fine Chemicals Private Limited).